German experience with low intensity anticoagulation (GELIA): protocol of a multi-center randomized, prospective study with the St. Jude Medical valve

J Heart Valve Dis. 1993 Jul;2(4):411-9.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Clinical Trial, Phase III
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Acenocoumarol / administration & dosage
  • Acenocoumarol / adverse effects
  • Acenocoumarol / pharmacokinetics
  • Adult
  • Aged
  • Anticoagulants / administration & dosage*
  • Anticoagulants / adverse effects
  • Anticoagulants / pharmacokinetics
  • Aortic Valve / surgery*
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Germany
  • Heart Valve Diseases / blood
  • Heart Valve Diseases / mortality
  • Heart Valve Diseases / surgery*
  • Heart Valve Prosthesis*
  • Hemorrhage / blood
  • Hemorrhage / chemically induced
  • Hemorrhage / mortality
  • Humans
  • Male
  • Middle Aged
  • Mitral Valve / surgery*
  • Phenprocoumon / administration & dosage
  • Phenprocoumon / adverse effects
  • Phenprocoumon / pharmacokinetics
  • Postoperative Complications / blood
  • Postoperative Complications / mortality
  • Postoperative Complications / prevention & control*
  • Prospective Studies
  • Survival Rate
  • Thromboembolism / blood
  • Thromboembolism / mortality
  • Thromboembolism / prevention & control*
  • Warfarin / administration & dosage
  • Warfarin / adverse effects
  • Warfarin / pharmacokinetics

Substances

  • Anticoagulants
  • Warfarin
  • Acenocoumarol
  • Phenprocoumon